Mobile

A randomised, double blind, placebo-controlled, multicentre study in asymptomatic HIV infected patients to investigate pharmacodynamics, pharmacokinetics, safety and toleration of UK-453,061

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-004120-39

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Investigate the effects of 7-day monotherapy of UK-453,061 on viral load response in asymptomatic HIV infected patients and to assess the dose-response relationship. Assess the pharmacokinetics, safety and tolerability of UK-453,061 in asymptomatic HIV infected patients.

Critère d'inclusion

  • HIV

Liens